NCT06996873 is a clinical trial in Aggressive Spinal Hemangiomas, sponsored by Assiut University.

Who is sponsoring NCT06996873?

NCT06996873 is sponsored by Assiut University.

What condition does NCT06996873 study?

NCT06996873 studies Aggressive Spinal Hemangiomas.

Is NCT06996873 still recruiting?

NCT06996873 is currently not yet recruiting. Last updated 30 May 2025.

Last reviewed 2025-05-30 · How we verify

NCT06996873

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aggressive Spinal Hemangioma

Not yet recruiting Last updated 30 May 2025

What this trial tests

trial in Aggressive Spinal Hemangiomas in 30 participants. Not yet recruiting.

Timeline

30 June 2025

Primary endpoint
30 July 2026

30 December 2026

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	30
Start date	30 June 2025
Primary completion	30 July 2026
Estimated completion	30 December 2026

Conditions studied

Aggressive Spinal Hemangiomas — all drugs for Aggressive Spinal Hemangiomas →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Aggressive Spinal Hemangiomas. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is a case series analysis to evaluate aggressive vertebral hemangiomas. It focuses on clinical presentation, diagnostic imaging accuracy (X-ray, MRI, MSCT, angiography), and treatment efficacy. The primary goal is to establish optimal management protocols.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06996873 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 30 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06996873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing